Dr M Induscorp
No trades in 1Y
Key Insights
No strengths listed
Weaknesses
1- Company might be capitalizing the interest cost
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 10Y | Zero base |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | +69.81% |
Net profit
| 10Y | Zero base |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | Zero base |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | Turned negative |
Operating margin· change in pp
| 10Y | No sales |
|---|---|
| 5Y | Irregular period |
| 3Y | Irregular period |
| 1Y | 0.00 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2016 | ₹0.00 Cr |
|---|---|
| Mar 2017 | ₹0.00 Cr |
| Mar 2024 | ₹0.00 Cr |
| Mar 2025 | ₹265 Cr |
| Mar 2026 | ₹450 Cr |
Net profit by year
| Mar 2016 | ₹0.00 Cr |
|---|---|
| Mar 2017 | ₹0.00 Cr |
| Mar 2024 | ₹0.00 Cr |
| Mar 2025 | ₹0.00 Cr |
| Mar 2026 | ₹0.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.06 | 0.05 | 0.06 | 0.08 | 20.03 | 77.79 | 187 | 96.58 | 56.38 | 112 |
| Expenses | 0.12 | 0.11 | 0.15 | 0.15 | 20.18 | 76.57 | 188 | 95.74 | 56.35 | 110 |
| Operating Profit | −0.06 | −0.06 | −0.09 | −0.07 | −0.15 | 1.22 | −0.93 | 0.84 | 0.03 | 1.75 |
| OPM % | −100% | −120% | −150% | −87.5% | −0.75% | 1.57% | −0.5% | 0.87% | 0.05% | 1.56% |
| Other Income | 0.04 | 0.1 | 0.14 | 0.12 | 0.08 | 0.18 | 0.01 | 0 | 0.05 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.02 | 0.02 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.05 |
| PBT | −0.02 | 0.04 | 0.05 | 0.05 | −0.07 | 1.4 | −0.92 | 0.79 | 0.05 | 1.68 |
| Tax % | 0% | 0% | 0% | 0% | −57.14% | 22.14% | 0% | 0% | 40% | 33.33% |
| Net Profit | −0.02 | 0.04 | 0.05 | 0.04 | −0.03 | 1.09 | −0.93 | 0.79 | 0.03 | 1.12 |
The columns include both quarters and half years, as the company reported them.
Profit & Loss
₹ Cr| Particulars | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 265 | 450 |
| Expenses | 0 | 1 | 0 | 265 | 450 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| OPM % | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | 0% | 0.1% |
| Other Income | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | 0 | 0 | 0 | 0 |
| Tax % | 0% | 22% | 0% | 16% | 18% |
| Net Profit | 0 | 0 | 0 | 0 | 0 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 |
| Reserves | −5 | −5 | −5 | −5 | −5 |
| Borrowings | 0 | 0 | 0 | 2 | 2 |
| Other Liabilities | 0 | 0 | 0 | 7 | 13 |
| Total Liabilities | 3 | 3 | 2 | 12 | 18 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 3 | 3 | 2 | 11 | 18 |
| Total Assets | 3 | 3 | 2 | 12 | 18 |
Cash Flow
₹ Cr| Particulars | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 0 | 0 | −2 | 0 | −4 |
| Investing | 0 | 0 | 0 | 0 | 0 |
| Financing | 0 | 0 | 0 | 2 | 3 |
| Net Cash Flow | 0 | 0 | −1 | 2 | 0 |
| Free Cash Flow | 0 | 0 | −2 | 0 | −4 |
| CFO/OP | 0 | 0 | 577 | 750 | −1,396 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | — | — | — | 0 | — |
| Inventory Days | — | — | — | 0 | — |
| Cash Conversion Cycle | — | — | — | 0 | — |
| Working Capital Days | — | — | — | 3 | — |
| ROCE % | — | 3% | — | 12% | — |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Dr M Induscorp insights
28 extracted metrics across FY16–FY27.
Frequently Asked Questions about Dr M Induscorp
Where is Dr M Induscorp Ltd (519512) listed?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/519512.md for Dr M Induscorp Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.